These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1326909

  • 1. [The efficacy of transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
    Shimizu J, Kanai T, Monden M, Sakon M, Gotoh M, Umeshita K, Tarui T, Monden T, Mori T, Tomoda K.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1437-40. PubMed ID: 1326909
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases.
    Kanai T, Monden M, Sakon M, Gotoh M, Umeshita K, Hasuike Y, Nakano H, Monden T, Murakami T, Nakamura H.
    Cancer Chemother Pharmacol; 1994 Aug; 33 Suppl():S48-54. PubMed ID: 8137485
    [Abstract] [Full Text] [Related]

  • 7. [Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
    Inoue H, Kobayashi H, Kajiya Y, Hidaka H, Ikeda K.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):620-2. PubMed ID: 3006597
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Chemoembolization combined with hepatic arterial induction of endogenous TNF and anticancer agents for hepatocellular carcinoma--a case report].
    Takekoshi H.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1744-7. PubMed ID: 2167647
    [Abstract] [Full Text] [Related]

  • 12. [A clinical trial of transarterial chemoembolization for hepatocellular carcinoma using 4'-0-tetrahydropyranyladriamycin].
    Izumi N, Goto Y.
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1303-7. PubMed ID: 1695081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy of percutaneous transhepatic portal embolization for unresected cases of hepatocellular carcinoma].
    Okabe K, Beppu T, Masuda T, Hayashi H, Mizumoto T, Ishiko T, Okabe H, Sano O, Yamaanaka T, Baba H.
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1811-3. PubMed ID: 17212115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Segmental arterio-portal chemo-embolization in hepatocellular carcinoma (cement therapy)].
    Oi H, Yamamoto T, Sawai Y, Fujino M, Okamura J, Nakamura H.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2853-7. PubMed ID: 2551228
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.